Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Ekachai Medical Care Public Company Limited (EKH.BK)
THB5.05
+0.00 (+0.00%)
TH SET Healthcare Medical - Care Facilities
Address
99/9 Moo 4, Ekachai Road 74000
Muang, TH
Muang, TH
CEO
Amnuay Oerareemitr
Website
ekachaihospital.com
IPO
2016-07-27
ISIN TH7344010007
Description
Ekachai Medical Care Public Company Limited, along with its subsidiaries, operates the Ekachai hospital in Thailand. This facility provides a comprehensive range of medical services, including specialized areas such as plastic surgery, orthopedics, ophthalmology, and general surgery, as well as fertility and genetic treatments. It also caters to family health with pediatric, obstetrics, and gynecology services, and operates a dedicated child and teen development center. General medical care is available through its clinic, emergency services, and health promotion programs. Additional offerings include hemodialysis, dental care, physical therapy, aesthetic and dermatology services, mobile check-ups, and pre-employment screenings. The company was founded in 2003 and has its headquarters in Muang, Thailand.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
THB5.05
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
406.1K
Beta
-0.01
Float Shares
397.03M
Free Float %
49.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.81% | +1.63% | -0.99% | -3.85% | +0.40% | +0.81% | -15.97% | -34.30% | -13.94% | -17.22% | -17.22% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
5.05
DCF (Unlevered)
6.83
+35.2%
DCF (Levered)
4.67
-7.5%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
50% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | +1 |
| Buy | 1 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
8.12
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%-5.2% Q1'26: +2.1% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%-13.5% Q1'26: +0.4% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+16.9% Q1'26: -43.9% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+24.0% ★ Q1'26: +26.8% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+15.2% ★ Q1'26: +15.4% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+6.4% Q1'26: -7.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×0.20× ★ Q1'26: 0.16× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
502.13M
est: 505.00M (-0.6%)
|
522.98M
est: 523.00M (0.0%)
|
638.12M
est: 615.00M (+3.8%)
|
886.04M
est: 822.00M (+7.8%)
|
645.75M
est: 656.50M (-1.6%)
|
1.15B
est: 1.13B (+1.8%)
|
1.05B
est: 1.09B (-3.7%)
|
1.21B
est: 1.28B (-5.5%)
|
1.31B
est: 1.33B (-1.6%)
|
1.24B
est: 1.25B (-0.7%)
|
1.29B
1.28B – 1.31B
+3.7% YoY
|
1.40B
1.38B – 1.42B
+7.9% YoY
|
1.48B
1.47B – 1.49B
+6.1% YoY
|
| EBITDA |
117.47M
est: 214.10M (-45.1%)
|
130.57M
est: 221.73M (-41.1%)
|
178.24M
est: 260.74M (-31.6%)
|
253.54M
est: 348.50M (-27.2%)
|
150.62M
est: 278.33M (-45.9%)
|
501.66M
est: 477.60M (+5.0%)
|
763.85M
est: 461.49M (+65.5%)
|
460.25M
est: 561.14M (-18.0%)
|
443.88M
est: 582.86M (-23.8%)
|
381.55M
est: 547.72M (-30.3%)
|
568.20M
562.35M – 574.04M
+3.7% YoY
|
613.26M
605.79M – 621.60M
+7.9% YoY
|
650.63M
645.70M – 655.57M
+6.1% YoY
|
| EBIT |
93.40M
est: 175.26M (-46.7%)
|
102.09M
est: 181.50M (-43.8%)
|
143.72M
est: 213.43M (-32.7%)
|
206.62M
est: 285.27M (-27.6%)
|
81.15M
est: 227.83M (-64.4%)
|
426.56M
est: 390.94M (+9.1%)
|
687.36M
est: 377.75M (+82.0%)
|
374.45M
est: 472.84M (-20.8%)
|
355.45M
est: 491.14M (-27.6%)
|
296.94M
est: 461.53M (-35.7%)
|
478.78M
473.86M – 483.71M
+3.7% YoY
|
516.75M
510.46M – 523.78M
+7.9% YoY
|
548.25M
544.09M – 552.41M
+6.1% YoY
|
| Net Income |
75.27M
est: 91.28M (-17.5%)
|
83.83M
est: 98.30M (-14.7%)
|
117.21M
est: 133.41M (-12.1%)
|
160.30M
est: 187.25M (-14.4%)
|
72.10M
est: 65.53M (+10.0%)
|
344.83M
est: 387.94M (-11.1%)
|
551.32M
est: 405.41M (+36.0%)
|
297.26M
est: 348.87M (-14.8%)
|
280.06M
est: 282.72M (-0.9%)
|
262.30M
est: 250.96M (+4.5%)
|
234.80M
222.15M – 247.44M
-6.4% YoY
|
224.53M
220.96M – 228.09M
-4.4% YoY
|
220.48M
217.15M – 223.81M
-1.8% YoY
|
| SGA |
93.41M
est: 95.51M (-2.2%)
|
99.88M
est: 98.91M (+1.0%)
|
128.42M
est: 116.31M (+10.4%)
|
195.04M
est: 155.46M (+25.5%)
|
133.07M
est: 124.16M (+7.2%)
|
173.05M
est: 213.05M (-18.8%)
|
197.33M
est: 205.86M (-4.1%)
|
223.90M
est: 233.85M (-4.3%)
|
281.17M
est: 242.90M (+15.8%)
|
216.85M
est: 228.26M (-5.0%)
|
236.79M
234.36M – 239.23M
+3.7% YoY
|
255.57M
252.46M – 259.04M
+7.9% YoY
|
271.15M
269.09M – 273.20M
+6.1% YoY
|
| EPS |
0.14
est: 0.12 (+17.7%)
|
0.13
est: 0.13 (+1.5%)
|
0.18
est: 0.17 (+3.5%)
|
0.25
est: 0.24 (+2.4%)
|
0.11
est: 0.09 (+28.8%)
|
0.54
est: 0.51 (+6.8%)
|
0.84
est: 0.52 (+62.4%)
|
0.43
est: 0.43 (+0.6%)
|
0.37
est: 0.35 (+6.9%)
|
0.32
est: 0.31 (+4.1%)
|
0.29
0.27 – 0.30
-6.4% YoY
|
0.28
0.27 – 0.28
-4.2% YoY
|
0.27
0.27 – 0.27
-2.1% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-19 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-18 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-15 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-14 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-13 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-12 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-11 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-06 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-05 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-29 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-114.81M
OE per share TTM
-0.14
Owner's Yield
-2.87%
Maintenance CapEx ratio
146.56%
Maint CapEx / Avg PPE
73.4%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 2 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 19.2K | 0.39% |
| 2 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 16.1K | 0.28% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
593.9K
Shares Outstanding
800.00M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Amnuay Oerareemitr | Chief Executive Officer & Chairman | 437.0K | male |
| Suttipong Tangsajjapoj | Executive Vice President, Assistant of Hospital Director - Accounting & Finance and Executive Director | 422.0K | male |
| Pichamonch Patanapoonyapirom | Executive Director & Deputy of Hospital Director - Administration Division | 305.0K | female |
| Amnaj Eur-Areemitr | Hospital Director & Executive Director | 302.0K | — |
| Wanlop Popianthong | Executive Director | 287.0K | male |
| Kanchana Oerareemitr | Executive Director | 287.0K | female |
| Orasa Tangsajjapoj | Executive Director | 287.0K | female |
| Kaweechai Lertassawarat | Executive Director & Deputy of Hospital Director - Medical Department | 235.0K | — |
| Pattra Lertpunyaphol | Company Secretary | — | female |
| Monpat Bhumiratanajarin | Chief of Internal Audit | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for EKH.BK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
